Nephrocare India successfully closes pre-IPO funding;ropes in marquee investors
Telugu super news,Kolkata, December 29, 2023: City-based Nephrocare India, a comprehensive renal care institution founded by renowned nephrologist Dr. Pratim Sengupta, today announced the successful closure of its pre-IPO round. Marquee investors, including Deepak Parekh (veteran banker and former chairman of HDFC Ltd), Bharat Shah (Chairman, HDFC Securities) and Rajendra Agarwal (Founder and MD of Macleods Pharmaceuticals), among
others, participated in the funding round.
Founded in 2014, Nephrocare India has three kidney care clinics in West Bengal and a
flagship holistic healthcare facility in Salt Lake, Kolkata. Dr. Sengupta has a personal vision
of positively impacting the lives of close to one million patients suffering from chronic kidney
disease by setting up 300 Nephrocare centres across the country in the next 8-10 years,
replicating the already demonstrated hub and spoke strategy. Towards this goal, Nephrocare
India expects to set up 22 high-end comprehensive kidney care facilities across the country
by March 2026. Four centres will be opened by the end of the current fiscal year.
Kidney disease is a silent epidemic, and India is contributing the highest numbers of renal
failure patients in the world. An estimated 1 out of 11 Indians are likely to be a victim of renal
failure, the leading causes of which are said to be diabetes and hypertension. India, which is
often referred to as the ‘Diabetes Capital of the World’, adds close to 2.5 lakh new patients
every year to the pool of people requiring dialysis support due to advanced kidney failure.
There are around seven crore patients suffering from various chronic kidney diseases, but
only around 12,881 haemodialysis centres are capable of performing dialysis across the
country. There is a massive gap between the demand and supply of kidney care units in
India. Nephrocare India plans to bridge this gap by setting up holistic renal care units